A Randomized, Double-blind, Active-controlled, Non-inferiority, Multicenter Phase III Study to Evaluate the Efficacy and Safety of HCP1004 As Compared to RLD2401 in Chronic Low-Back Pain Patients
Latest Information Update: 15 Oct 2024
At a glance
- Drugs Esomeprazole/naproxen (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 15 Oct 2024 New trial record